HK1117746A1 - Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use - Google Patents

Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Info

Publication number
HK1117746A1
HK1117746A1 HK08108684.6A HK08108684A HK1117746A1 HK 1117746 A1 HK1117746 A1 HK 1117746A1 HK 08108684 A HK08108684 A HK 08108684A HK 1117746 A1 HK1117746 A1 HK 1117746A1
Authority
HK
Hong Kong
Prior art keywords
polypeptides
methods
compositions containing
gram positive
immunizing compositions
Prior art date
Application number
HK08108684.6A
Other languages
English (en)
Inventor
Daryll A Emery
Darren E Straub
Laura Wonderling
Olson Lisa L Herron
Original Assignee
Epitopix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitopix Llc filed Critical Epitopix Llc
Publication of HK1117746A1 publication Critical patent/HK1117746A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1285—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Corynebacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
HK08108684.6A 2005-02-14 2008-08-07 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use HK1117746A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65284305P 2005-02-14 2005-02-14
PCT/US2006/005058 WO2006088803A2 (en) 2005-02-14 2006-02-14 Polypeptides from staphylococcus aureus and methods of use

Publications (1)

Publication Number Publication Date
HK1117746A1 true HK1117746A1 (en) 2009-01-23

Family

ID=36694403

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08108684.6A HK1117746A1 (en) 2005-02-14 2008-08-07 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Country Status (13)

Country Link
US (13) US8007811B2 (xx)
EP (1) EP1853306B1 (xx)
JP (3) JP2008532935A (xx)
CN (2) CN103143006B (xx)
AU (1) AU2006214534B2 (xx)
BR (1) BRPI0607323B8 (xx)
CA (1) CA2597263C (xx)
DK (1) DK1853306T3 (xx)
ES (1) ES2586125T3 (xx)
HK (1) HK1117746A1 (xx)
MX (1) MX2007009828A (xx)
NZ (4) NZ589238A (xx)
WO (1) WO2006088803A2 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
AU1915995A (en) * 1994-02-09 1995-08-29 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
PT1353689E (pt) * 2001-01-03 2006-08-31 Epitopix Llc Composicoes imunizantes e metodos de utilizacao
US8119147B2 (en) 2003-09-19 2012-02-21 Epitopix, Llc Compositions produced using enteric pathogens and methods of use
WO2006088803A2 (en) 2005-02-14 2006-08-24 Epitopix, Llc Polypeptides from staphylococcus aureus and methods of use
WO2007100580A2 (en) * 2006-02-22 2007-09-07 The Texas A & M University System Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use
EP2502628B1 (en) * 2006-06-23 2016-12-14 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
MX336869B (es) 2008-11-03 2016-02-04 Alethia Biotherapeutics Inc Anticuerpos que bloquean espicificamente la actividad biologica de un antigeno de tumor.
NZ614557A (en) 2009-03-23 2015-03-27 Epitopix Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
KR101993259B1 (ko) 2011-03-31 2019-06-27 에이디씨 테라퓨틱스 에스에이 신장 결합 항원 １에 대한 항체 및 이의 항원 결합 단편
DK2802351T3 (da) 2012-01-09 2019-05-13 Adc Therapeutics Sa Midler til behandling af triple-negativ brystkræft
AU2013203774A1 (en) * 2012-01-27 2013-08-15 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for immunization against bacteria expressing a carbapenemase
US10100093B2 (en) 2013-12-31 2018-10-16 Epitopix Llc Polypeptides and immunizing compositions containing Burkholderia polypeptides and methods of use
MX2018000395A (es) 2015-07-10 2018-05-23 Epitopix Llc Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.
WO2017024038A1 (en) * 2015-08-03 2017-02-09 The Arizona Board Of Regents On Behalf Of The University Of Arizona Solar concentrator for a tower-mounted central receiver
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
TWI733412B (zh) * 2020-04-13 2021-07-11 華邦電子股份有限公司 具有氣隙之半導體元件及其製造方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5554372A (en) 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
AU1915995A (en) * 1994-02-09 1995-08-29 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6403337B1 (en) * 1996-01-05 2002-06-11 Human Genome Sciences, Inc. Staphylococcus aureus genes and polypeptides
ATE309271T1 (de) * 1996-05-16 2005-11-15 Texas A & M Univ Sys Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen
US6680195B1 (en) * 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
US6703025B1 (en) * 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
AU2001249345A1 (en) 2000-03-21 2001-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes
AT410173B (de) * 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
PT1353689E (pt) * 2001-01-03 2006-08-31 Epitopix Llc Composicoes imunizantes e metodos de utilizacao
AT410798B (de) 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
WO2002102829A2 (en) * 2001-06-15 2002-12-27 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
WO2003020875A2 (en) * 2001-06-17 2003-03-13 D-Squared Biotechnologies, Inc. Staphylococci surface-exposed immunogenic polypeptides
US6720160B2 (en) * 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
WO2004013166A2 (en) 2002-07-26 2004-02-12 Intercell Ag S. aureus antigene
US6947260B2 (en) * 2002-11-18 2005-09-20 Hitachi Global Storage Technologies Netherlands B.V. System and method of damping vibration on coil supports in high performance disk drives with rotary actuators
US8119147B2 (en) * 2003-09-19 2012-02-21 Epitopix, Llc Compositions produced using enteric pathogens and methods of use
US20070128183A1 (en) * 2004-04-27 2007-06-07 Intercell Ag Td antigens
KR20070057864A (ko) 2004-08-26 2007-06-07 더 유니버시티 오브 웨스턴 온타리오 철 운반의 억제제를 포함하는 약제 조성물, 및 철 운반억제제를 동정하는 방법
KR20070085457A (ko) 2004-10-25 2007-08-27 더 유니버시티 오브 웨스턴 온타리오 스태필로코쿠스 아우레우스의 철에 의해 조절되는 표면결정인자 ＩｓｄＡ, ＩｓｄＢ, 및 ＩｓｄＣ 기재 백신,조성물 및 방법
WO2006088803A2 (en) * 2005-02-14 2006-08-24 Epitopix, Llc Polypeptides from staphylococcus aureus and methods of use
NZ614557A (en) 2009-03-23 2015-03-27 Epitopix Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Also Published As

Publication number Publication date
US20070087011A1 (en) 2007-04-19
US8007811B2 (en) 2011-08-30
US20130287813A1 (en) 2013-10-31
US20140005360A1 (en) 2014-01-02
US8961979B2 (en) 2015-02-24
US8709760B2 (en) 2014-04-29
JP6100826B2 (ja) 2017-03-22
AU2006214534B2 (en) 2012-07-19
NZ589238A (en) 2012-02-24
US8025885B2 (en) 2011-09-27
CA2597263C (en) 2017-01-17
CN101119744A (zh) 2008-02-06
US20120164685A1 (en) 2012-06-28
NZ613923A (en) 2015-02-27
US20150210757A1 (en) 2015-07-30
US20100221253A1 (en) 2010-09-02
NZ560612A (en) 2011-01-28
CA2597263A1 (en) 2006-08-24
US20160068590A9 (en) 2016-03-10
US20170182146A1 (en) 2017-06-29
AU2006214534A1 (en) 2006-08-24
CN101119744B (zh) 2013-03-13
BRPI0607323B1 (pt) 2020-12-22
US20130288952A1 (en) 2013-10-31
MX2007009828A (es) 2007-09-27
JP2008532935A (ja) 2008-08-21
JP2015155457A (ja) 2015-08-27
EP1853306A2 (en) 2007-11-14
NZ597997A (en) 2013-10-25
EP1853306B1 (en) 2016-06-15
US8709436B2 (en) 2014-04-29
US8007803B2 (en) 2011-08-30
DK1853306T3 (en) 2016-09-05
CN103143006A (zh) 2013-06-12
US20150023969A1 (en) 2015-01-22
US9266944B2 (en) 2016-02-23
JP2013053155A (ja) 2013-03-21
US9981028B2 (en) 2018-05-29
BRPI0607323B8 (pt) 2021-05-25
US20060233824A1 (en) 2006-10-19
WO2006088803A2 (en) 2006-08-24
BRPI0607323A2 (pt) 2009-09-01
US20160158312A1 (en) 2016-06-09
WO2006088803A3 (en) 2006-12-21
US20080200650A1 (en) 2008-08-21
US20130280300A1 (en) 2013-10-24
US9623076B2 (en) 2017-04-18
ES2586125T3 (es) 2016-10-11
CN103143006B (zh) 2016-08-03

Similar Documents

Publication Publication Date Title
HK1117746A1 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
MX2007008723A (es) Polipeptidos de yersinia spp y metodos de uso.
TW200732349A (en) Anti-OX40L antibodies and methods using same
MX2007005221A (es) Formas cristalinas de ascomicina y preparacion de ellas.
IL244803A0 (en) Human anti-beta7 antibodies and their use
MX2007006178A (es) Fenoles substituidos como agentes activos que inhiben la produccion del factor de crecimiento endotelial vascular.
MXPA05013553A (es) Pirrolodihidroisoquinolinas como inhibidores de pde10.
TNSN07222A1 (en) Nematicidal compositions
WO2008121767A3 (en) Stitched polypeptides
TW200727920A (en) New regimens for oral monophasic contraceptives
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
WO2008103935A3 (en) Novel tobacco compositions and methods of making
WO2006104945A3 (en) Hepatitis c therapies
WO2007130697A8 (en) Anti-ephb4 antibodies and methods using same
MX339461B (es) Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso.
WO2008013589A3 (en) Treatment of ras-expressing tumors
WO2005087793A3 (en) Immunostimulatory compositions and uses thereof
TW200800967A (en) Benzimidazole thiophene compounds
TW200732410A (en) Sprayable acoustic compositions
TW200716088A (en) Formulations and methods for treating amyloidosis
MY145788A (en) Antitumoral dihydropyran-2-one compounds
WO2007127506A3 (en) Anti-ephrinb2 antibodies and methods using same
WO2006133006A3 (en) 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
MY163037A (en) Endoparasiticidal compositions
ZA200604874B (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: CORRECTION OF THE ENGLISH TITLE OF INVENTION FROM POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPERPTIDES AND METHODS OF USE TO POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPEPTIDES AND METHODS OF USE

Effective date: 20131128

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190211